雲頂新耀(01952.HK)與騰訊(00700.HK)達成戰略商業合作夥伴關係
雲頂新耀(01952.HK)公布,與騰訊(00700.HK)達成戰略商業合作夥伴關係,探索以數字化創新方式優化對患者和醫藥健康提供者的服務。公司將與騰訊共同探索一系列能力建設與潛在的解決方案,包括與患者和醫療專業人士共同開展相關疾病,特別是針對各種癌症、腎病和嚴重感染性疾病的健康教育。雙方並將考慮建立一站式的患者管理體系,涵蓋從診斷、治療到結果的全程疾病管理,並研究如何利用人工智能和商業智能工具,更好地識別患者需求,改進治療方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.